2023-05-012024-04-302024-04-30false09566199PR PSYCHIATRY LTD2024-10-21iso4217:GBPxbrli:pure095661992023-05-01095661992024-04-30095661992023-05-012024-04-30095661992022-05-01095661992023-04-30095661992022-05-012023-04-3009566199bus:SmallEntities2023-05-012024-04-3009566199bus:AuditExempt-NoAccountantsReport2023-05-012024-04-3009566199bus:FullAccounts2023-05-012024-04-3009566199bus:PrivateLimitedCompanyLtd2023-05-012024-04-3009566199core:WithinOneYear2024-04-3009566199core:AfterOneYear2024-04-3009566199core:WithinOneYear2023-04-3009566199core:AfterOneYear2023-04-3009566199core:ShareCapital2024-04-3009566199core:SharePremium2024-04-3009566199core:RevaluationReserve2024-04-3009566199core:OtherReservesSubtotal2024-04-3009566199core:RetainedEarningsAccumulatedLosses2024-04-3009566199core:ShareCapital2023-04-3009566199core:SharePremium2023-04-3009566199core:RevaluationReserve2023-04-3009566199core:OtherReservesSubtotal2023-04-3009566199core:RetainedEarningsAccumulatedLosses2023-04-3009566199core:LandBuildings2024-04-3009566199core:PlantMachinery2024-04-3009566199core:Vehicles2024-04-3009566199core:FurnitureFittings2024-04-3009566199core:OfficeEquipment2024-04-3009566199core:NetGoodwill2024-04-3009566199core:IntangibleAssetsOtherThanGoodwill2024-04-3009566199core:ListedExchangeTraded2024-04-3009566199core:UnlistedNon-exchangeTraded2024-04-3009566199core:LandBuildings2023-04-3009566199core:PlantMachinery2023-04-3009566199core:Vehicles2023-04-3009566199core:FurnitureFittings2023-04-3009566199core:OfficeEquipment2023-04-3009566199core:NetGoodwill2023-04-3009566199core:IntangibleAssetsOtherThanGoodwill2023-04-3009566199core:ListedExchangeTraded2023-04-3009566199core:UnlistedNon-exchangeTraded2023-04-3009566199core:LandBuildings2023-05-012024-04-3009566199core:PlantMachinery2023-05-012024-04-3009566199core:Vehicles2023-05-012024-04-3009566199core:FurnitureFittings2023-05-012024-04-3009566199core:OfficeEquipment2023-05-012024-04-3009566199core:NetGoodwill2023-05-012024-04-3009566199core:IntangibleAssetsOtherThanGoodwill2023-05-012024-04-3009566199core:ListedExchangeTraded2023-05-012024-04-3009566199core:UnlistedNon-exchangeTraded2023-05-012024-04-3009566199core:MoreThanFiveYears2023-05-012024-04-3009566199core:Non-currentFinancialInstruments2024-04-3009566199core:Non-currentFinancialInstruments2023-04-3009566199dpl:CostSales2023-05-012024-04-3009566199dpl:DistributionCosts2023-05-012024-04-3009566199core:LandBuildings2023-05-012024-04-3009566199core:PlantMachinery2023-05-012024-04-3009566199core:Vehicles2023-05-012024-04-3009566199core:FurnitureFittings2023-05-012024-04-3009566199core:OfficeEquipment2023-05-012024-04-3009566199dpl:AdministrativeExpenses2023-05-012024-04-3009566199core:NetGoodwill2023-05-012024-04-3009566199core:IntangibleAssetsOtherThanGoodwill2023-05-012024-04-3009566199dpl:GroupUndertakings2023-05-012024-04-3009566199dpl:ParticipatingInterests2023-05-012024-04-3009566199dpl:GroupUndertakingscore:ListedExchangeTraded2023-05-012024-04-3009566199core:ListedExchangeTraded2023-05-012024-04-3009566199dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-05-012024-04-3009566199core:UnlistedNon-exchangeTraded2023-05-012024-04-3009566199dpl:CostSales2022-05-012023-04-3009566199dpl:DistributionCosts2022-05-012023-04-3009566199core:LandBuildings2022-05-012023-04-3009566199core:PlantMachinery2022-05-012023-04-3009566199core:Vehicles2022-05-012023-04-3009566199core:FurnitureFittings2022-05-012023-04-3009566199core:OfficeEquipment2022-05-012023-04-3009566199dpl:AdministrativeExpenses2022-05-012023-04-3009566199core:NetGoodwill2022-05-012023-04-3009566199core:IntangibleAssetsOtherThanGoodwill2022-05-012023-04-3009566199dpl:GroupUndertakings2022-05-012023-04-3009566199dpl:ParticipatingInterests2022-05-012023-04-3009566199dpl:GroupUndertakingscore:ListedExchangeTraded2022-05-012023-04-3009566199core:ListedExchangeTraded2022-05-012023-04-3009566199dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-05-012023-04-3009566199core:UnlistedNon-exchangeTraded2022-05-012023-04-3009566199core:NetGoodwill2024-04-3009566199core:IntangibleAssetsOtherThanGoodwill2024-04-3009566199core:LandBuildings2024-04-3009566199core:PlantMachinery2024-04-3009566199core:Vehicles2024-04-3009566199core:FurnitureFittings2024-04-3009566199core:OfficeEquipment2024-04-3009566199core:AfterOneYear2024-04-3009566199core:WithinOneYear2024-04-3009566199core:ListedExchangeTraded2024-04-3009566199core:UnlistedNon-exchangeTraded2024-04-3009566199core:ShareCapital2024-04-3009566199core:SharePremium2024-04-3009566199core:RevaluationReserve2024-04-3009566199core:OtherReservesSubtotal2024-04-3009566199core:RetainedEarningsAccumulatedLosses2024-04-3009566199core:NetGoodwill2023-04-3009566199core:IntangibleAssetsOtherThanGoodwill2023-04-3009566199core:LandBuildings2023-04-3009566199core:PlantMachinery2023-04-3009566199core:Vehicles2023-04-3009566199core:FurnitureFittings2023-04-3009566199core:OfficeEquipment2023-04-3009566199core:AfterOneYear2023-04-3009566199core:WithinOneYear2023-04-3009566199core:ListedExchangeTraded2023-04-3009566199core:UnlistedNon-exchangeTraded2023-04-3009566199core:ShareCapital2023-04-3009566199core:SharePremium2023-04-3009566199core:RevaluationReserve2023-04-3009566199core:OtherReservesSubtotal2023-04-3009566199core:RetainedEarningsAccumulatedLosses2023-04-3009566199core:NetGoodwill2022-05-0109566199core:IntangibleAssetsOtherThanGoodwill2022-05-0109566199core:LandBuildings2022-05-0109566199core:PlantMachinery2022-05-0109566199core:Vehicles2022-05-0109566199core:FurnitureFittings2022-05-0109566199core:OfficeEquipment2022-05-0109566199core:AfterOneYear2022-05-0109566199core:WithinOneYear2022-05-0109566199core:ListedExchangeTraded2022-05-0109566199core:UnlistedNon-exchangeTraded2022-05-0109566199core:ShareCapital2022-05-0109566199core:SharePremium2022-05-0109566199core:RevaluationReserve2022-05-0109566199core:OtherReservesSubtotal2022-05-0109566199core:RetainedEarningsAccumulatedLosses2022-05-0109566199core:AfterOneYear2023-05-012024-04-3009566199core:WithinOneYear2023-05-012024-04-3009566199core:Non-currentFinancialInstrumentscore:CostValuation2023-05-012024-04-3009566199core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-05-012024-04-3009566199core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-05-012024-04-3009566199core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-05-012024-04-3009566199core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-05-012024-04-3009566199core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-05-012024-04-3009566199core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-05-012024-04-3009566199core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-05-012024-04-3009566199core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-05-012024-04-3009566199core:Non-currentFinancialInstrumentscore:CostValuation2024-04-3009566199core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-3009566199core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-3009566199core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-3009566199core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-3009566199core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-3009566199core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-3009566199core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-3009566199core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-3009566199core:Non-currentFinancialInstrumentscore:CostValuation2023-04-3009566199core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-04-3009566199core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-04-3009566199core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-04-3009566199core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-04-3009566199core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-04-3009566199core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-04-3009566199core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-04-3009566199core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-04-3009566199bus:Director12023-05-012024-04-3009566199bus:Director22023-05-012024-04-3009566199core:FurnitureFittingsToolsEquipment2023-04-3009566199core:FurnitureFittingsToolsEquipment2024-04-3009566199core:FurnitureFittingsToolsEquipment2023-05-012024-04-30

PR PSYCHIATRY LTD

Registered Number
09566199
(England and Wales)

Unaudited Financial Statements for the Year ended
30 April 2024

PR PSYCHIATRY LTD
Company Information
for the year from 1 May 2023 to 30 April 2024

Directors

PRAKASH, Reshma
RAVIRAJ, Prakash

Registered Address

Epr Consulting Rooms Dr Prakash Raviraj
16b Station Road
Cheadle Hulme
SK8 5AE

Registered Number

09566199 (England and Wales)
PR PSYCHIATRY LTD
Balance Sheet as at
30 April 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets35,7617,087
5,7617,087
Current assets
Debtors7,7935,248
Cash at bank and on hand191,248159,532
199,041164,780
Creditors amounts falling due within one year4(29,448)(17,327)
Net current assets (liabilities)169,593147,453
Total assets less current liabilities175,354154,540
Provisions for liabilities5(1,095)(1,347)
Net assets174,259153,193
Capital and reserves
Called up share capital100100
Profit and loss account174,159153,093
Shareholders' funds174,259153,193
The financial statements were approved and authorised for issue by the Board of Directors on 21 October 2024, and are signed on its behalf by:
PRAKASH, Reshma
Director
RAVIRAJ, Prakash
Director

Registered Company No. 09566199
PR PSYCHIATRY LTD
Notes to the Financial Statements
for the year ended 30 April 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:
2.Average number of employees

20242023
Average number of employees during the year22
3.Tangible fixed assets

Fixtures & fittings

Office Equipment

Total

£££
Cost or valuation
At 01 May 234,8008,67513,475
At 30 April 244,8008,67513,475
Depreciation and impairment
At 01 May 233506,0386,388
Charge for year6686581,326
At 30 April 241,0186,6967,714
Net book value
At 30 April 243,7821,9795,761
At 30 April 234,4502,6377,087
4.Creditors: amounts due within one year

2024

2023

££
Bank borrowings and overdrafts-740
Taxation and social security5,4282,629
Other creditors22,52212,596
Accrued liabilities and deferred income1,4981,362
Total29,44817,327
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
5.Provisions for liabilities

2024

2023

££
Net deferred tax liability (asset)1,0951,347
Total1,0951,347